CAPTRUST Financial Advisors
AZN icon

CAPTRUST Financial Advisors’s AstraZeneca AZN Stock Holding History

CAPTRUST Financial Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6M Sell
77,194
-1,760
-2% -$331K 0.02% 472
2026
Q1 		$15.6M Buy
78,954
+7,830
+11% +$1.51M 0.03% 424
2025
Q4 		$13.1M Buy
71,124
+195
+0.3% +$34.2K 0.02% 425
2025
Q3 		$10.9M Sell
70,929
-4,229
-6% -$640K 0.02% 456
2025
Q2 		$10.5M Sell
75,158
-995
-1% -$139K 0.02% 452
2025
Q1 		$11.2M Buy
76,153
+16,308
+27% +$2.36M 0.03% 403
2024
Q4 		$7.84M Sell
59,845
-8,722
-13% -$1.22M 0.02% 425
2024
Q3 		$10.7M Sell
68,567
-4,000
-6% -$646K 0.03% 365
2024
Q2 		$11.3M Buy
72,567
+9,393
+15% +$1.41M 0.04% 332
2024
Q1 		$8.56M Buy
63,174
+1,772
+3% +$235K 0.03% 372
2023
Q4 		$8.27M Buy
61,402
+2,492
+4% +$324K 0.03% 408
2023
Q3 		$7.98M Buy
58,910
+2,468
+4% +$337K 0.03% 381
2023
Q2 		$8.08M Sell
56,442
-2,228
-4% -$328K 0.03% 372
2023
Q1 		$8.14M Buy
58,670
+3,851
+7% +$518K 0.04% 334
2022
Q4 		$7.43M Buy
54,819
+5,410
+11% +$678K 0.04% 349
2022
Q3 		$5.42M Buy
49,409
+17,555
+55% +$2.23M 0.03% 378
2022
Q2 		$4.21M Buy
31,854
+1,677
+6% +$220K 0.03% 407
2022
Q1 		$4M Buy
30,177
+3,477
+13% +$417K 0.03% 412
2021
Q4 		$3.11M Buy
26,700
+1,041
+4% +$122K 0.02% 460
2021
Q3 		$3.08M Buy
25,659
+9,525
+59% +$1.11M 0.03% 423
2021
Q2 		$1.93M Sell
16,134
-552
-3% -$60.6K 0.02% 513
2021
Q1 		$1.66M Sell
16,686
-137
-0.8% -$13.8K 0.02% 515
2020
Q4 		$1.68M Sell
16,823
-3,960
-19% -$419K 0.02% 452
2020
Q3 		$2.26M Buy
20,783
+435
+2% +$48.4K 0.04% 332
2020
Q2 		$2.17M Buy
20,348
+1,720
+9% +$178K 0.04% 331
2020
Q1 		$1.63M Sell
18,628
-324
-2% -$30.5K 0.04% 331
2019
Q4 		$1.91M Buy
+18,952
New +$1.78M 0.03% 376

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

CAPTRUST Financial Advisors's AZN Position: Q2 2026 in Review

CAPTRUST Financial Advisors reduced its AstraZeneca (AZN) stake by 2.2% in Q2 2026, selling an estimated $331K and leaving 77,194 shares worth $14.6M. The position accounts for 0.02% of the portfolio, ranked #472.

CAPTRUST Financial Advisors first reported a position in AZN in Q4 2019 and has held it in 27 quarters since. The position peaked at $15.6M in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • CAPTRUST Financial Advisors held 77,194 shares of AstraZeneca worth $14.6M as of Q2 2026.
  • CAPTRUST Financial Advisors sold 1,760 AstraZeneca shares in Q2 2026, an estimated $331K.
  • AstraZeneca made up 0.02% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #472 holding.
  • CAPTRUST Financial Advisors first reported a position in AstraZeneca in Q4 2019 and has held it in 27 quarters since.
  • CAPTRUST Financial Advisors's AstraZeneca position peaked at $15.6M in Q1 2026.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.